Theriva Biologics TOVX
NYSE TOVX
$0.21 +0.00 (+1.68%)
As of: Oct 21, 2026 · 11:29 AM EDT

Theriva Biologics (TOVX) Current Debt (2025 - 2026)

Updated

Theriva Biologics' Current Debt was -$11,000 in Q2 2026, compared with -$11,000 a year earlier.

Analysis

Theriva Biologics (TOVX) Current Debt (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Theriva Biologics' Current Debt was -$63,000 through Jun 30, 2026; for FY2025, it came in at -$70,000.

  • In earlier years, Current Debt was -$67,000 in FY2024.
  • Quarterly Current Debt has moved between -$56,000 (Q1 2025) and -$1,000 (Q4 2025) over five years.
  • Per Business Quant data, TOVX's Current Debt in the three quarters before Q2 2026 was -$49,000 (Q1 2026), -$1,000 (Q4 2025) and -$2,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -5.75 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 64.00 Mn
10 Theriva Biologics 9.71 Mn -36.65 Mn - -11,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,000.00
Mar 31, 2026 -49,000.00
Dec 31, 2025 -1,000.00
Sep 30, 2025 -2,000.00
Jun 30, 2025 -11,000.00
Mar 31, 2025 -56,000.00
API Access

Theriva Biologics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TOVX&period=max&api_key=YOUR_API_KEY